Twitter | Search | |
This is the legacy version of twitter.com. We will be shutting it down on 15 December 2020. Please switch to a supported browser or device. You can see a list of supported browsers in our Help Center.
Yuval Shaked
We will find the way to defeat cancer
41
Tweets
70
Following
41
Followers
Tweets
Yuval Shaked retweeted
OncoHost Nov 18
“The ability to adequately assess, and potentially predict, response and resistance to immunotherapy will lead to better outcomes for patients,” - the American Society of Clinical Oncology. Read more about our new developments in cancer care & research:
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Nov 25
With over 220,000 new cases of lung cancer a year, lung cancer is the third most common cancer in the US. As November is lung cancer awareness month, do your part to help educate others:
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Nov 11
Cancer immunotherapy focuses on the immune system and carries a big promise for cancer patients. Therefore, it is crucial when considering a treatment plan, we go beyond the drug-tumor interaction and understand a patient's unique response to treatment.
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Nov 9
We are excited to present our most recent study at SITC 2020! The study examines the use of plasma-based proteomic profiling as a clinically insightful tool for oncologists to identify new targets in overcoming treatment resistance. Read more:
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Nov 4
Preliminary findings in a recent trial show the use of specific heart drugs boosts the performance of immunotherapy in some patients. These findings show the potential of personalized treatment, and what can be achieved when combining treatments safely.
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Nov 2
Immunotherapy can play a significant role in the fight against cancer, but there are also serious side effects including itchy and painful skin reactions. Japanese researchers have discovered the cause of these reactions which could help prevent them.
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Oct 7
Skepticism surrounding the use of AI in healthcare is fairly widespread, specifically in personalized treatment. However, we need to realize that isn’t here to replace medical professionals, but rather to assist them. Read more here:
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Oct 5
We look forward to presenting our data on predicting to at the MAP 2020 Virtual Congress! Join us, Oct. 9th at 17:20PM CEST to see Prof. , co-founder & Chief Scientific Advisor at OncoHost deliver the presentation.
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Sep 23
OncoHost co-founder, Professor Yuval Shaked, will be presenting tomorrow, September 24th at Virtual Conference on Lung Cancer at 10:00AM EST. Yuval will discuss “Host Response to Anti-Cancer Therapy and its Clinical Implications”.
Reply Retweet Like
Yuval Shaked Sep 17
New data on prediction of immunotherapy outcome
Reply Retweet Like
Yuval Shaked retweeted
Technion Israel Sep 2
Replying to @ShakedYuval
Reply Retweet Like
Yuval Shaked Aug 27
Replying to @jitcancer
The immunological role of IL31 in cancer - seems like family of IL6
Reply Retweet Like
Yuval Shaked retweeted
Yuval Shaked Aug 25
Tumor-educated uncommitted hematopoietic stem cells promote a metastatic switch | bioRxiv. In this study we show how tumor cells hijack hematopoietic stem cell differentiation leading to the accumulation of metastatic supporting cells.
Reply Retweet Like
Yuval Shaked Aug 25
Tumor-educated uncommitted hematopoietic stem cells promote a metastatic switch | bioRxiv. In this study we show how tumor cells hijack hematopoietic stem cell differentiation leading to the accumulation of metastatic supporting cells.
Reply Retweet Like
Yuval Shaked retweeted
Iacovos Michael Aug 25
Tumor-educated uncommitted hematopoietic stem cells promote a metastatic switch, by
Reply Retweet Like
Yuval Shaked retweeted
Journal for ImmunoTherapy of Cancer Aug 25
New article: IL-31 induces antitumor immunity in breast carcinoma
Reply Retweet Like
Yuval Shaked retweeted
OncoHost Mar 2
Read about a new method being implemented by researchers and scientists that reduces tumor size.
Reply Retweet Like
Yuval Shaked retweeted
Science|Business Feb 19
Despite advances in , rates of resistance & recurrence remain stubbornly high. An Israeli project, backed & , is showing promising results overcoming challenges of resistance & recurrence ➡️
Reply Retweet Like
Yuval Shaked retweeted
Science|Business Feb 24
Israeli researcher, , is taking a bold approach to precision medicine aiming to undermine ’s defence mechanisms. Backed by grants, Shaked is developing novel methods to fight cancer resistance & recurrence 🔬
Reply Retweet Like
Yuval Shaked retweeted
Science|Business Feb 21
Israeli researcher, , is taking a bold approach to precision medicine aiming to undermine ’s defence mechanisms. Backed by grants, Shaked is developing novel methods to fight cancer resistance & recurrence 🔬
Reply Retweet Like